- call +1-201-465-4211
- email sales@marketquest.biz
- Call +1-201-465-4211
- Email: sales@marketquest.biz
An orally disintegrating tablet or orally dissolving tablet (ODT) is a drug dosage form available for a limited range of over-the-counter (OTC) and prescription medications.An excipient is a pharmacologically inert adhesive substance used to bind the contents of a pill or tablet. This type of tablet separates in the mouth in contact with saliva, making it easy for a person to swallow the tablet without drinking water.
According to our latest study, the global Orally Disintegrating Tablet Excipient market size was valued at USD 17130 million in 2022 and is forecast to a readjusted size of USD 21580 million by 2029 with a CAGR of 3.3% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
McePharma (Vivesa holding) was the global greatest company in Orally Disintegrating Tablet Excipient industry, with the revenue market Share of 3% , followed by BASF, JRS Pharma, Roquette, ABF Ingredients, DFE Pharma, Evonik, Merck KGaA, Ashland, Meggle Pharma, Shin-Etsu, Fuji Chemical Industries, Cargill Incorporated, Daicel Corporation, Anhui Sunhere Pharmaceutical.APAC is the largest Orally Disintegrating Tablet Excipient market with about 30% market share. Americas is follower, accounting for about 27% market share.
This report is a detailed and comprehensive analysis for global Orally Disintegrating Tablet Excipient market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Orally Disintegrating Tablet Excipient market size and forecasts, in consumption value ($ Million), sales quantity (K MT), and average selling prices (USD/MT), 2018-2029
Global Orally Disintegrating Tablet Excipient market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K MT), and average selling prices (USD/MT), 2018-2029
Global Orally Disintegrating Tablet Excipient market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K MT), and average selling prices (USD/MT), 2018-2029
Global Orally Disintegrating Tablet Excipient market shares of main players, shipments in revenue ($ Million), sales quantity (K MT), and ASP (USD/MT), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Orally Disintegrating Tablet Excipient
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Orally Disintegrating Tablet Excipient market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include BASF, JRS Pharma, Roquette, ABF Ingredients and DFE Pharma, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Orally Disintegrating Tablet Excipient market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Binders
Glidents
Diluents
Disintegrants
Others
Market segment by Application
Anti-Psychotics Drug
Anti-Epileptics Drug
Others
Major players covered
BASF
JRS Pharma
Roquette
ABF Ingredients
DFE Pharma
Evonik
Merck KGaA
Ashland
Meggle Pharma
Shin-Etsu
Fuji Chemical Industries
McePharma (Vivesa holding)
Cargill Incorporated
Daicel Corporation
Anhui Sunhere Pharmaceutical
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Orally Disintegrating Tablet Excipient product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Orally Disintegrating Tablet Excipient, with price, sales, revenue and global market share of Orally Disintegrating Tablet Excipient from 2018 to 2023.
Chapter 3, the Orally Disintegrating Tablet Excipient competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Orally Disintegrating Tablet Excipient breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Orally Disintegrating Tablet Excipient market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Orally Disintegrating Tablet Excipient.
Chapter 14 and 15, to describe Orally Disintegrating Tablet Excipient sales channel, distributors, customers, research findings and conclusion.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Product Overview and Scope of Orally Disintegrating Tablet Excipient
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Orally Disintegrating Tablet Excipient Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Binders
1.3.3 Glidents
1.3.4 Diluents
1.3.5 Disintegrants
1.3.6 Others
1.4 Market Analysis by Application
1.4.1 Overview: Global Orally Disintegrating Tablet Excipient Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Anti-Psychotics Drug
1.4.3 Anti-Epileptics Drug
1.4.4 Others
1.5 Global Orally Disintegrating Tablet Excipient Market Size & Forecast
1.5.1 Global Orally Disintegrating Tablet Excipient Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Orally Disintegrating Tablet Excipient Sales Quantity (2018-2029)
1.5.3 Global Orally Disintegrating Tablet Excipient Average Price (2018-2029)
2 Manufacturers Profiles
2.1 BASF
2.1.1 BASF Details
2.1.2 BASF Major Business
2.1.3 BASF Orally Disintegrating Tablet Excipient Product and Services
2.1.4 BASF Orally Disintegrating Tablet Excipient Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 BASF Recent Developments/Updates
2.2 JRS Pharma
2.2.1 JRS Pharma Details
2.2.2 JRS Pharma Major Business
2.2.3 JRS Pharma Orally Disintegrating Tablet Excipient Product and Services
2.2.4 JRS Pharma Orally Disintegrating Tablet Excipient Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 JRS Pharma Recent Developments/Updates
2.3 Roquette
2.3.1 Roquette Details
2.3.2 Roquette Major Business
2.3.3 Roquette Orally Disintegrating Tablet Excipient Product and Services
2.3.4 Roquette Orally Disintegrating Tablet Excipient Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Roquette Recent Developments/Updates
2.4 ABF Ingredients
2.4.1 ABF Ingredients Details
2.4.2 ABF Ingredients Major Business
2.4.3 ABF Ingredients Orally Disintegrating Tablet Excipient Product and Services
2.4.4 ABF Ingredients Orally Disintegrating Tablet Excipient Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 ABF Ingredients Recent Developments/Updates
2.5 DFE Pharma
2.5.1 DFE Pharma Details
2.5.2 DFE Pharma Major Business
2.5.3 DFE Pharma Orally Disintegrating Tablet Excipient Product and Services
2.5.4 DFE Pharma Orally Disintegrating Tablet Excipient Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 DFE Pharma Recent Developments/Updates
2.6 Evonik
2.6.1 Evonik Details
2.6.2 Evonik Major Business
2.6.3 Evonik Orally Disintegrating Tablet Excipient Product and Services
2.6.4 Evonik Orally Disintegrating Tablet Excipient Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Evonik Recent Developments/Updates
2.7 Merck KGaA
2.7.1 Merck KGaA Details
2.7.2 Merck KGaA Major Business
2.7.3 Merck KGaA Orally Disintegrating Tablet Excipient Product and Services
2.7.4 Merck KGaA Orally Disintegrating Tablet Excipient Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Merck KGaA Recent Developments/Updates
2.8 Ashland
2.8.1 Ashland Details
2.8.2 Ashland Major Business
2.8.3 Ashland Orally Disintegrating Tablet Excipient Product and Services
2.8.4 Ashland Orally Disintegrating Tablet Excipient Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Ashland Recent Developments/Updates
2.9 Meggle Pharma
2.9.1 Meggle Pharma Details
2.9.2 Meggle Pharma Major Business
2.9.3 Meggle Pharma Orally Disintegrating Tablet Excipient Product and Services
2.9.4 Meggle Pharma Orally Disintegrating Tablet Excipient Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Meggle Pharma Recent Developments/Updates
2.10 Shin-Etsu
2.10.1 Shin-Etsu Details
2.10.2 Shin-Etsu Major Business
2.10.3 Shin-Etsu Orally Disintegrating Tablet Excipient Product and Services
2.10.4 Shin-Etsu Orally Disintegrating Tablet Excipient Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Shin-Etsu Recent Developments/Updates
2.11 Fuji Chemical Industries
2.11.1 Fuji Chemical Industries Details
2.11.2 Fuji Chemical Industries Major Business
2.11.3 Fuji Chemical Industries Orally Disintegrating Tablet Excipient Product and Services
2.11.4 Fuji Chemical Industries Orally Disintegrating Tablet Excipient Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Fuji Chemical Industries Recent Developments/Updates
2.12 McePharma (Vivesa holding)
2.12.1 McePharma (Vivesa holding) Details
2.12.2 McePharma (Vivesa holding) Major Business
2.12.3 McePharma (Vivesa holding) Orally Disintegrating Tablet Excipient Product and Services
2.12.4 McePharma (Vivesa holding) Orally Disintegrating Tablet Excipient Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 McePharma (Vivesa holding) Recent Developments/Updates
2.13 Cargill Incorporated
2.13.1 Cargill Incorporated Details
2.13.2 Cargill Incorporated Major Business
2.13.3 Cargill Incorporated Orally Disintegrating Tablet Excipient Product and Services
2.13.4 Cargill Incorporated Orally Disintegrating Tablet Excipient Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Cargill Incorporated Recent Developments/Updates
2.14 Daicel Corporation
2.14.1 Daicel Corporation Details
2.14.2 Daicel Corporation Major Business
2.14.3 Daicel Corporation Orally Disintegrating Tablet Excipient Product and Services
2.14.4 Daicel Corporation Orally Disintegrating Tablet Excipient Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Daicel Corporation Recent Developments/Updates
2.15 Anhui Sunhere Pharmaceutical
2.15.1 Anhui Sunhere Pharmaceutical Details
2.15.2 Anhui Sunhere Pharmaceutical Major Business
2.15.3 Anhui Sunhere Pharmaceutical Orally Disintegrating Tablet Excipient Product and Services
2.15.4 Anhui Sunhere Pharmaceutical Orally Disintegrating Tablet Excipient Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Anhui Sunhere Pharmaceutical Recent Developments/Updates
3 Competitive Environment: Orally Disintegrating Tablet Excipient by Manufacturer
3.1 Global Orally Disintegrating Tablet Excipient Sales Quantity by Manufacturer (2018-2023)
3.2 Global Orally Disintegrating Tablet Excipient Revenue by Manufacturer (2018-2023)
3.3 Global Orally Disintegrating Tablet Excipient Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Orally Disintegrating Tablet Excipient by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Orally Disintegrating Tablet Excipient Manufacturer Market Share in 2022
3.4.2 Top 6 Orally Disintegrating Tablet Excipient Manufacturer Market Share in 2022
3.5 Orally Disintegrating Tablet Excipient Market: Overall Company Footprint Analysis
3.5.1 Orally Disintegrating Tablet Excipient Market: Region Footprint
3.5.2 Orally Disintegrating Tablet Excipient Market: Company Product Type Footprint
3.5.3 Orally Disintegrating Tablet Excipient Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Orally Disintegrating Tablet Excipient Market Size by Region
4.1.1 Global Orally Disintegrating Tablet Excipient Sales Quantity by Region (2018-2029)
4.1.2 Global Orally Disintegrating Tablet Excipient Consumption Value by Region (2018-2029)
4.1.3 Global Orally Disintegrating Tablet Excipient Average Price by Region (2018-2029)
4.2 North America Orally Disintegrating Tablet Excipient Consumption Value (2018-2029)
4.3 Europe Orally Disintegrating Tablet Excipient Consumption Value (2018-2029)
4.4 Asia-Pacific Orally Disintegrating Tablet Excipient Consumption Value (2018-2029)
4.5 South America Orally Disintegrating Tablet Excipient Consumption Value (2018-2029)
4.6 Middle East and Africa Orally Disintegrating Tablet Excipient Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Orally Disintegrating Tablet Excipient Sales Quantity by Type (2018-2029)
5.2 Global Orally Disintegrating Tablet Excipient Consumption Value by Type (2018-2029)
5.3 Global Orally Disintegrating Tablet Excipient Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Orally Disintegrating Tablet Excipient Sales Quantity by Application (2018-2029)
6.2 Global Orally Disintegrating Tablet Excipient Consumption Value by Application (2018-2029)
6.3 Global Orally Disintegrating Tablet Excipient Average Price by Application (2018-2029)
7 North America
7.1 North America Orally Disintegrating Tablet Excipient Sales Quantity by Type (2018-2029)
7.2 North America Orally Disintegrating Tablet Excipient Sales Quantity by Application (2018-2029)
7.3 North America Orally Disintegrating Tablet Excipient Market Size by Country
7.3.1 North America Orally Disintegrating Tablet Excipient Sales Quantity by Country (2018-2029)
7.3.2 North America Orally Disintegrating Tablet Excipient Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Orally Disintegrating Tablet Excipient Sales Quantity by Type (2018-2029)
8.2 Europe Orally Disintegrating Tablet Excipient Sales Quantity by Application (2018-2029)
8.3 Europe Orally Disintegrating Tablet Excipient Market Size by Country
8.3.1 Europe Orally Disintegrating Tablet Excipient Sales Quantity by Country (2018-2029)
8.3.2 Europe Orally Disintegrating Tablet Excipient Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Orally Disintegrating Tablet Excipient Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Orally Disintegrating Tablet Excipient Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Orally Disintegrating Tablet Excipient Market Size by Region
9.3.1 Asia-Pacific Orally Disintegrating Tablet Excipient Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Orally Disintegrating Tablet Excipient Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Orally Disintegrating Tablet Excipient Sales Quantity by Type (2018-2029)
10.2 South America Orally Disintegrating Tablet Excipient Sales Quantity by Application (2018-2029)
10.3 South America Orally Disintegrating Tablet Excipient Market Size by Country
10.3.1 South America Orally Disintegrating Tablet Excipient Sales Quantity by Country (2018-2029)
10.3.2 South America Orally Disintegrating Tablet Excipient Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Orally Disintegrating Tablet Excipient Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Orally Disintegrating Tablet Excipient Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Orally Disintegrating Tablet Excipient Market Size by Country
11.3.1 Middle East & Africa Orally Disintegrating Tablet Excipient Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Orally Disintegrating Tablet Excipient Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Orally Disintegrating Tablet Excipient Market Drivers
12.2 Orally Disintegrating Tablet Excipient Market Restraints
12.3 Orally Disintegrating Tablet Excipient Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Orally Disintegrating Tablet Excipient and Key Manufacturers
13.2 Manufacturing Costs Percentage of Orally Disintegrating Tablet Excipient
13.3 Orally Disintegrating Tablet Excipient Production Process
13.4 Orally Disintegrating Tablet Excipient Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Orally Disintegrating Tablet Excipient Typical Distributors
14.3 Orally Disintegrating Tablet Excipient Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
List of Tables
Table 1. Global Orally Disintegrating Tablet Excipient Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Orally Disintegrating Tablet Excipient Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. BASF Basic Information, Manufacturing Base and Competitors
Table 4. BASF Major Business
Table 5. BASF Orally Disintegrating Tablet Excipient Product and Services
Table 6. BASF Orally Disintegrating Tablet Excipient Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. BASF Recent Developments/Updates
Table 8. JRS Pharma Basic Information, Manufacturing Base and Competitors
Table 9. JRS Pharma Major Business
Table 10. JRS Pharma Orally Disintegrating Tablet Excipient Product and Services
Table 11. JRS Pharma Orally Disintegrating Tablet Excipient Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. JRS Pharma Recent Developments/Updates
Table 13. Roquette Basic Information, Manufacturing Base and Competitors
Table 14. Roquette Major Business
Table 15. Roquette Orally Disintegrating Tablet Excipient Product and Services
Table 16. Roquette Orally Disintegrating Tablet Excipient Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Roquette Recent Developments/Updates
Table 18. ABF Ingredients Basic Information, Manufacturing Base and Competitors
Table 19. ABF Ingredients Major Business
Table 20. ABF Ingredients Orally Disintegrating Tablet Excipient Product and Services
Table 21. ABF Ingredients Orally Disintegrating Tablet Excipient Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. ABF Ingredients Recent Developments/Updates
Table 23. DFE Pharma Basic Information, Manufacturing Base and Competitors
Table 24. DFE Pharma Major Business
Table 25. DFE Pharma Orally Disintegrating Tablet Excipient Product and Services
Table 26. DFE Pharma Orally Disintegrating Tablet Excipient Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. DFE Pharma Recent Developments/Updates
Table 28. Evonik Basic Information, Manufacturing Base and Competitors
Table 29. Evonik Major Business
Table 30. Evonik Orally Disintegrating Tablet Excipient Product and Services
Table 31. Evonik Orally Disintegrating Tablet Excipient Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Evonik Recent Developments/Updates
Table 33. Merck KGaA Basic Information, Manufacturing Base and Competitors
Table 34. Merck KGaA Major Business
Table 35. Merck KGaA Orally Disintegrating Tablet Excipient Product and Services
Table 36. Merck KGaA Orally Disintegrating Tablet Excipient Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Merck KGaA Recent Developments/Updates
Table 38. Ashland Basic Information, Manufacturing Base and Competitors
Table 39. Ashland Major Business
Table 40. Ashland Orally Disintegrating Tablet Excipient Product and Services
Table 41. Ashland Orally Disintegrating Tablet Excipient Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Ashland Recent Developments/Updates
Table 43. Meggle Pharma Basic Information, Manufacturing Base and Competitors
Table 44. Meggle Pharma Major Business
Table 45. Meggle Pharma Orally Disintegrating Tablet Excipient Product and Services
Table 46. Meggle Pharma Orally Disintegrating Tablet Excipient Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Meggle Pharma Recent Developments/Updates
Table 48. Shin-Etsu Basic Information, Manufacturing Base and Competitors
Table 49. Shin-Etsu Major Business
Table 50. Shin-Etsu Orally Disintegrating Tablet Excipient Product and Services
Table 51. Shin-Etsu Orally Disintegrating Tablet Excipient Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Shin-Etsu Recent Developments/Updates
Table 53. Fuji Chemical Industries Basic Information, Manufacturing Base and Competitors
Table 54. Fuji Chemical Industries Major Business
Table 55. Fuji Chemical Industries Orally Disintegrating Tablet Excipient Product and Services
Table 56. Fuji Chemical Industries Orally Disintegrating Tablet Excipient Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Fuji Chemical Industries Recent Developments/Updates
Table 58. McePharma (Vivesa holding) Basic Information, Manufacturing Base and Competitors
Table 59. McePharma (Vivesa holding) Major Business
Table 60. McePharma (Vivesa holding) Orally Disintegrating Tablet Excipient Product and Services
Table 61. McePharma (Vivesa holding) Orally Disintegrating Tablet Excipient Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. McePharma (Vivesa holding) Recent Developments/Updates
Table 63. Cargill Incorporated Basic Information, Manufacturing Base and Competitors
Table 64. Cargill Incorporated Major Business
Table 65. Cargill Incorporated Orally Disintegrating Tablet Excipient Product and Services
Table 66. Cargill Incorporated Orally Disintegrating Tablet Excipient Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 67. Cargill Incorporated Recent Developments/Updates
Table 68. Daicel Corporation Basic Information, Manufacturing Base and Competitors
Table 69. Daicel Corporation Major Business
Table 70. Daicel Corporation Orally Disintegrating Tablet Excipient Product and Services
Table 71. Daicel Corporation Orally Disintegrating Tablet Excipient Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 72. Daicel Corporation Recent Developments/Updates
Table 73. Anhui Sunhere Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 74. Anhui Sunhere Pharmaceutical Major Business
Table 75. Anhui Sunhere Pharmaceutical Orally Disintegrating Tablet Excipient Product and Services
Table 76. Anhui Sunhere Pharmaceutical Orally Disintegrating Tablet Excipient Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Anhui Sunhere Pharmaceutical Recent Developments/Updates
Table 78. Global Orally Disintegrating Tablet Excipient Sales Quantity by Manufacturer (2018-2023) & (K MT)
Table 79. Global Orally Disintegrating Tablet Excipient Revenue by Manufacturer (2018-2023) & (USD Million)
Table 80. Global Orally Disintegrating Tablet Excipient Average Price by Manufacturer (2018-2023) & (USD/MT)
Table 81. Market Position of Manufacturers in Orally Disintegrating Tablet Excipient, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 82. Head Office and Orally Disintegrating Tablet Excipient Production Site of Key Manufacturer
Table 83. Orally Disintegrating Tablet Excipient Market: Company Product Type Footprint
Table 84. Orally Disintegrating Tablet Excipient Market: Company Product Application Footprint
Table 85. Orally Disintegrating Tablet Excipient New Market Entrants and Barriers to Market Entry
Table 86. Orally Disintegrating Tablet Excipient Mergers, Acquisition, Agreements, and Collaborations
Table 87. Global Orally Disintegrating Tablet Excipient Sales Quantity by Region (2018-2023) & (K MT)
Table 88. Global Orally Disintegrating Tablet Excipient Sales Quantity by Region (2024-2029) & (K MT)
Table 89. Global Orally Disintegrating Tablet Excipient Consumption Value by Region (2018-2023) & (USD Million)
Table 90. Global Orally Disintegrating Tablet Excipient Consumption Value by Region (2024-2029) & (USD Million)
Table 91. Global Orally Disintegrating Tablet Excipient Average Price by Region (2018-2023) & (USD/MT)
Table 92. Global Orally Disintegrating Tablet Excipient Average Price by Region (2024-2029) & (USD/MT)
Table 93. Global Orally Disintegrating Tablet Excipient Sales Quantity by Type (2018-2023) & (K MT)
Table 94. Global Orally Disintegrating Tablet Excipient Sales Quantity by Type (2024-2029) & (K MT)
Table 95. Global Orally Disintegrating Tablet Excipient Consumption Value by Type (2018-2023) & (USD Million)
Table 96. Global Orally Disintegrating Tablet Excipient Consumption Value by Type (2024-2029) & (USD Million)
Table 97. Global Orally Disintegrating Tablet Excipient Average Price by Type (2018-2023) & (USD/MT)
Table 98. Global Orally Disintegrating Tablet Excipient Average Price by Type (2024-2029) & (USD/MT)
Table 99. Global Orally Disintegrating Tablet Excipient Sales Quantity by Application (2018-2023) & (K MT)
Table 100. Global Orally Disintegrating Tablet Excipient Sales Quantity by Application (2024-2029) & (K MT)
Table 101. Global Orally Disintegrating Tablet Excipient Consumption Value by Application (2018-2023) & (USD Million)
Table 102. Global Orally Disintegrating Tablet Excipient Consumption Value by Application (2024-2029) & (USD Million)
Table 103. Global Orally Disintegrating Tablet Excipient Average Price by Application (2018-2023) & (USD/MT)
Table 104. Global Orally Disintegrating Tablet Excipient Average Price by Application (2024-2029) & (USD/MT)
Table 105. North America Orally Disintegrating Tablet Excipient Sales Quantity by Type (2018-2023) & (K MT)
Table 106. North America Orally Disintegrating Tablet Excipient Sales Quantity by Type (2024-2029) & (K MT)
Table 107. North America Orally Disintegrating Tablet Excipient Sales Quantity by Application (2018-2023) & (K MT)
Table 108. North America Orally Disintegrating Tablet Excipient Sales Quantity by Application (2024-2029) & (K MT)
Table 109. North America Orally Disintegrating Tablet Excipient Sales Quantity by Country (2018-2023) & (K MT)
Table 110. North America Orally Disintegrating Tablet Excipient Sales Quantity by Country (2024-2029) & (K MT)
Table 111. North America Orally Disintegrating Tablet Excipient Consumption Value by Country (2018-2023) & (USD Million)
Table 112. North America Orally Disintegrating Tablet Excipient Consumption Value by Country (2024-2029) & (USD Million)
Table 113. Europe Orally Disintegrating Tablet Excipient Sales Quantity by Type (2018-2023) & (K MT)
Table 114. Europe Orally Disintegrating Tablet Excipient Sales Quantity by Type (2024-2029) & (K MT)
Table 115. Europe Orally Disintegrating Tablet Excipient Sales Quantity by Application (2018-2023) & (K MT)
Table 116. Europe Orally Disintegrating Tablet Excipient Sales Quantity by Application (2024-2029) & (K MT)
Table 117. Europe Orally Disintegrating Tablet Excipient Sales Quantity by Country (2018-2023) & (K MT)
Table 118. Europe Orally Disintegrating Tablet Excipient Sales Quantity by Country (2024-2029) & (K MT)
Table 119. Europe Orally Disintegrating Tablet Excipient Consumption Value by Country (2018-2023) & (USD Million)
Table 120. Europe Orally Disintegrating Tablet Excipient Consumption Value by Country (2024-2029) & (USD Million)
Table 121. Asia-Pacific Orally Disintegrating Tablet Excipient Sales Quantity by Type (2018-2023) & (K MT)
Table 122. Asia-Pacific Orally Disintegrating Tablet Excipient Sales Quantity by Type (2024-2029) & (K MT)
Table 123. Asia-Pacific Orally Disintegrating Tablet Excipient Sales Quantity by Application (2018-2023) & (K MT)
Table 124. Asia-Pacific Orally Disintegrating Tablet Excipient Sales Quantity by Application (2024-2029) & (K MT)
Table 125. Asia-Pacific Orally Disintegrating Tablet Excipient Sales Quantity by Region (2018-2023) & (K MT)
Table 126. Asia-Pacific Orally Disintegrating Tablet Excipient Sales Quantity by Region (2024-2029) & (K MT)
Table 127. Asia-Pacific Orally Disintegrating Tablet Excipient Consumption Value by Region (2018-2023) & (USD Million)
Table 128. Asia-Pacific Orally Disintegrating Tablet Excipient Consumption Value by Region (2024-2029) & (USD Million)
Table 129. South America Orally Disintegrating Tablet Excipient Sales Quantity by Type (2018-2023) & (K MT)
Table 130. South America Orally Disintegrating Tablet Excipient Sales Quantity by Type (2024-2029) & (K MT)
Table 131. South America Orally Disintegrating Tablet Excipient Sales Quantity by Application (2018-2023) & (K MT)
Table 132. South America Orally Disintegrating Tablet Excipient Sales Quantity by Application (2024-2029) & (K MT)
Table 133. South America Orally Disintegrating Tablet Excipient Sales Quantity by Country (2018-2023) & (K MT)
Table 134. South America Orally Disintegrating Tablet Excipient Sales Quantity by Country (2024-2029) & (K MT)
Table 135. South America Orally Disintegrating Tablet Excipient Consumption Value by Country (2018-2023) & (USD Million)
Table 136. South America Orally Disintegrating Tablet Excipient Consumption Value by Country (2024-2029) & (USD Million)
Table 137. Middle East & Africa Orally Disintegrating Tablet Excipient Sales Quantity by Type (2018-2023) & (K MT)
Table 138. Middle East & Africa Orally Disintegrating Tablet Excipient Sales Quantity by Type (2024-2029) & (K MT)
Table 139. Middle East & Africa Orally Disintegrating Tablet Excipient Sales Quantity by Application (2018-2023) & (K MT)
Table 140. Middle East & Africa Orally Disintegrating Tablet Excipient Sales Quantity by Application (2024-2029) & (K MT)
Table 141. Middle East & Africa Orally Disintegrating Tablet Excipient Sales Quantity by Region (2018-2023) & (K MT)
Table 142. Middle East & Africa Orally Disintegrating Tablet Excipient Sales Quantity by Region (2024-2029) & (K MT)
Table 143. Middle East & Africa Orally Disintegrating Tablet Excipient Consumption Value by Region (2018-2023) & (USD Million)
Table 144. Middle East & Africa Orally Disintegrating Tablet Excipient Consumption Value by Region (2024-2029) & (USD Million)
Table 145. Orally Disintegrating Tablet Excipient Raw Material
Table 146. Key Manufacturers of Orally Disintegrating Tablet Excipient Raw Materials
Table 147. Orally Disintegrating Tablet Excipient Typical Distributors
Table 148. Orally Disintegrating Tablet Excipient Typical Customers
List of Figures
Figure 1. Orally Disintegrating Tablet Excipient Picture
Figure 2. Global Orally Disintegrating Tablet Excipient Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Orally Disintegrating Tablet Excipient Consumption Value Market Share by Type in 2022
Figure 4. Binders Examples
Figure 5. Glidents Examples
Figure 6. Diluents Examples
Figure 7. Disintegrants Examples
Figure 8. Others Examples
Figure 9. Global Orally Disintegrating Tablet Excipient Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 10. Global Orally Disintegrating Tablet Excipient Consumption Value Market Share by Application in 2022
Figure 11. Anti-Psychotics Drug Examples
Figure 12. Anti-Epileptics Drug Examples
Figure 13. Others Examples
Figure 14. Global Orally Disintegrating Tablet Excipient Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 15. Global Orally Disintegrating Tablet Excipient Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 16. Global Orally Disintegrating Tablet Excipient Sales Quantity (2018-2029) & (K MT)
Figure 17. Global Orally Disintegrating Tablet Excipient Average Price (2018-2029) & (USD/MT)
Figure 18. Global Orally Disintegrating Tablet Excipient Sales Quantity Market Share by Manufacturer in 2022
Figure 19. Global Orally Disintegrating Tablet Excipient Consumption Value Market Share by Manufacturer in 2022
Figure 20. Producer Shipments of Orally Disintegrating Tablet Excipient by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 21. Top 3 Orally Disintegrating Tablet Excipient Manufacturer (Consumption Value) Market Share in 2022
Figure 22. Top 6 Orally Disintegrating Tablet Excipient Manufacturer (Consumption Value) Market Share in 2022
Figure 23. Global Orally Disintegrating Tablet Excipient Sales Quantity Market Share by Region (2018-2029)
Figure 24. Global Orally Disintegrating Tablet Excipient Consumption Value Market Share by Region (2018-2029)
Figure 25. North America Orally Disintegrating Tablet Excipient Consumption Value (2018-2029) & (USD Million)
Figure 26. Europe Orally Disintegrating Tablet Excipient Consumption Value (2018-2029) & (USD Million)
Figure 27. Asia-Pacific Orally Disintegrating Tablet Excipient Consumption Value (2018-2029) & (USD Million)
Figure 28. South America Orally Disintegrating Tablet Excipient Consumption Value (2018-2029) & (USD Million)
Figure 29. Middle East & Africa Orally Disintegrating Tablet Excipient Consumption Value (2018-2029) & (USD Million)
Figure 30. Global Orally Disintegrating Tablet Excipient Sales Quantity Market Share by Type (2018-2029)
Figure 31. Global Orally Disintegrating Tablet Excipient Consumption Value Market Share by Type (2018-2029)
Figure 32. Global Orally Disintegrating Tablet Excipient Average Price by Type (2018-2029) & (USD/MT)
Figure 33. Global Orally Disintegrating Tablet Excipient Sales Quantity Market Share by Application (2018-2029)
Figure 34. Global Orally Disintegrating Tablet Excipient Consumption Value Market Share by Application (2018-2029)
Figure 35. Global Orally Disintegrating Tablet Excipient Average Price by Application (2018-2029) & (USD/MT)
Figure 36. North America Orally Disintegrating Tablet Excipient Sales Quantity Market Share by Type (2018-2029)
Figure 37. North America Orally Disintegrating Tablet Excipient Sales Quantity Market Share by Application (2018-2029)
Figure 38. North America Orally Disintegrating Tablet Excipient Sales Quantity Market Share by Country (2018-2029)
Figure 39. North America Orally Disintegrating Tablet Excipient Consumption Value Market Share by Country (2018-2029)
Figure 40. United States Orally Disintegrating Tablet Excipient Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 41. Canada Orally Disintegrating Tablet Excipient Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 42. Mexico Orally Disintegrating Tablet Excipient Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 43. Europe Orally Disintegrating Tablet Excipient Sales Quantity Market Share by Type (2018-2029)
Figure 44. Europe Orally Disintegrating Tablet Excipient Sales Quantity Market Share by Application (2018-2029)
Figure 45. Europe Orally Disintegrating Tablet Excipient Sales Quantity Market Share by Country (2018-2029)
Figure 46. Europe Orally Disintegrating Tablet Excipient Consumption Value Market Share by Country (2018-2029)
Figure 47. Germany Orally Disintegrating Tablet Excipient Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. France Orally Disintegrating Tablet Excipient Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. United Kingdom Orally Disintegrating Tablet Excipient Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. Russia Orally Disintegrating Tablet Excipient Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 51. Italy Orally Disintegrating Tablet Excipient Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 52. Asia-Pacific Orally Disintegrating Tablet Excipient Sales Quantity Market Share by Type (2018-2029)
Figure 53. Asia-Pacific Orally Disintegrating Tablet Excipient Sales Quantity Market Share by Application (2018-2029)
Figure 54. Asia-Pacific Orally Disintegrating Tablet Excipient Sales Quantity Market Share by Region (2018-2029)
Figure 55. Asia-Pacific Orally Disintegrating Tablet Excipient Consumption Value Market Share by Region (2018-2029)
Figure 56. China Orally Disintegrating Tablet Excipient Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Japan Orally Disintegrating Tablet Excipient Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Korea Orally Disintegrating Tablet Excipient Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. India Orally Disintegrating Tablet Excipient Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. Southeast Asia Orally Disintegrating Tablet Excipient Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 61. Australia Orally Disintegrating Tablet Excipient Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 62. South America Orally Disintegrating Tablet Excipient Sales Quantity Market Share by Type (2018-2029)
Figure 63. South America Orally Disintegrating Tablet Excipient Sales Quantity Market Share by Application (2018-2029)
Figure 64. South America Orally Disintegrating Tablet Excipient Sales Quantity Market Share by Country (2018-2029)
Figure 65. South America Orally Disintegrating Tablet Excipient Consumption Value Market Share by Country (2018-2029)
Figure 66. Brazil Orally Disintegrating Tablet Excipient Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 67. Argentina Orally Disintegrating Tablet Excipient Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 68. Middle East & Africa Orally Disintegrating Tablet Excipient Sales Quantity Market Share by Type (2018-2029)
Figure 69. Middle East & Africa Orally Disintegrating Tablet Excipient Sales Quantity Market Share by Application (2018-2029)
Figure 70. Middle East & Africa Orally Disintegrating Tablet Excipient Sales Quantity Market Share by Region (2018-2029)
Figure 71. Middle East & Africa Orally Disintegrating Tablet Excipient Consumption Value Market Share by Region (2018-2029)
Figure 72. Turkey Orally Disintegrating Tablet Excipient Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Egypt Orally Disintegrating Tablet Excipient Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. Saudi Arabia Orally Disintegrating Tablet Excipient Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 75. South Africa Orally Disintegrating Tablet Excipient Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 76. Orally Disintegrating Tablet Excipient Market Drivers
Figure 77. Orally Disintegrating Tablet Excipient Market Restraints
Figure 78. Orally Disintegrating Tablet Excipient Market Trends
Figure 79. Porters Five Forces Analysis
Figure 80. Manufacturing Cost Structure Analysis of Orally Disintegrating Tablet Excipient in 2022
Figure 81. Manufacturing Process Analysis of Orally Disintegrating Tablet Excipient
Figure 82. Orally Disintegrating Tablet Excipient Industrial Chain
Figure 83. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 84. Direct Channel Pros & Cons
Figure 85. Indirect Channel Pros & Cons
Figure 86. Methodology
Figure 87. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
